Correlation Between Acrivon Therapeutics, and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Indaptus Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Indaptus Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Indaptus Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acrivon and Indaptus is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Indaptus Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 2.28 times less return on investment than Indaptus Therapeutics. In addition to that, Acrivon Therapeutics, is 1.22 times more volatile than Indaptus Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Indaptus Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 85.00 in Indaptus Therapeutics on November 2, 2024 and sell it today you would earn a total of 7.00 from holding Indaptus Therapeutics or generate 8.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Indaptus Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Indaptus Therapeutics |
Acrivon Therapeutics, and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Indaptus Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |